Table 2 Caspase-3 examination panel

1

Without exposure

Negative control

2

Cisplatin 100 µg/(10 µL)

Positive control

3

Without exposure

CD34 APC, CD40 PE, CD154 FITC

4

Without exposure

CD34 APC, Caspase-3 FITC

5

rhTNFα 48 ng

CD34 APC, Caspase-3 FITC

6

Without exposure

CD33 PE, Caspase-3 FITC

7

rhTNFα 48 ng/well

CD34 APC, CD33 PE, Caspase-3 FITC

8

Without exposure

CD41 PE, Caspase-3 FITC

9

rhTNFα 48 ng/well

CD34 APC, CD41a PE, Caspase-3 FITC

10

Without exposure

CD73 PE, Caspase-3 FITC

11

rhTNFα 48 ng/well

CD34 APC, CD73 PE, Caspase-3 FITC